| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Fernanda Veloso Pereira, Vinícius de Menezes Jarry, José Thiago Souza Castro, Simone Appenzeller, Fabiano Rei. Pediatric inflammatory demyelinating disorders and mimickers: How to differentiate with MRI? Autoimmunity reviews. vol 20. issue 5. 2021-04-20. PMID:33727154. |
the main imaging patterns of pediatric inflammatory demyelinating disorders and mimicking entities, including multiple sclerosis, neuromyelitis optica spectrum disorders, acute disseminated encephalomyelitis, mog (myelin oligodendrocyte glycoprotein) antibody-related disorders and differential diagnoses will be addressed in this article, highlighting key points to the differential diagnosis. |
2021-04-20 |
2023-08-13 |
Not clear |
| John R Ciotti, Noah S Eby, Matthew R Brier, Gregory F Wu, Salim Chahin, Anne H Cross, Robert T Naismit. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). 2021-04-19. PMID:33870786. |
central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica. |
2021-04-19 |
2023-08-13 |
Not clear |
| John R Ciotti, Noah S Eby, Matthew R Brier, Gregory F Wu, Salim Chahin, Anne H Cross, Robert T Naismit. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). 2021-04-19. PMID:33870786. |
myelin oligodendrocyte glycoprotein antibody disease (mogad) can radiographically mimic multiple sclerosis (ms) and aquaporin-4 (aqp4) antibody-positive neuromyelitis optica spectrum disorder (nmosd). |
2021-04-19 |
2023-08-13 |
Not clear |
| Ilya Ayzenberg, Ingo Kleite. [Treatment of antibody-mediated encephalomyelitis : Strategies for the treatment of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease]. Der Nervenarzt. vol 92. issue 4. 2021-04-09. PMID:33783551. |
[treatment of antibody-mediated encephalomyelitis : strategies for the treatment of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease]. |
2021-04-09 |
2023-08-13 |
Not clear |
| Ilya Ayzenberg, Ingo Kleite. [Treatment of antibody-mediated encephalomyelitis : Strategies for the treatment of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease]. Der Nervenarzt. vol 92. issue 4. 2021-04-09. PMID:33783551. |
antibody-mediated encephalomyelitis, such as neuromyelitis optica spectrum disorder (nmosd), myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), and glial fibrillary acidic protein (gfap) antibody-associated astrocytopathy belong to a group of newly described autoimmune diseases. |
2021-04-09 |
2023-08-13 |
Not clear |
| Sven Jarius, Brigitte Wildeman. [Aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis. A brief review]. Der Nervenarzt. vol 92. issue 4. 2021-04-09. PMID:33787942. |
[aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis. |
2021-04-09 |
2023-08-13 |
Not clear |
| Sven Jarius, Brigitte Wildeman. [Aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis. A brief review]. Der Nervenarzt. vol 92. issue 4. 2021-04-09. PMID:33787942. |
aquaporin 4 (aqp4) immunoglobulin (ig)g-associated neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein immunoglobulin (ig)g-associated encephalomyelitis (mog-em, also termed mog antibody-associated disease, mogad) are important autoimmune differential diagnoses of multiple sclerosis (ms), which differ from ms with respect to optimum treatment and prognosis. |
2021-04-09 |
2023-08-13 |
Not clear |
| Livia Sophie Hofer, Melanie Ramberger, Viktoria Gredler, Anna Sophie Pescoller, Kevin Rostásy, Mireia Sospedra, Harald Hegen, Thomas Berger, Andreas Lutterotti, Markus Reind. Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases. Frontiers in immunology. vol 11. 2021-04-05. PMID:32625206. |
autoantibodies against aquaporin-4 (aqp4-ab) and myelin oligodendrocyte glycoprotein (mog-ab) are associated with rare central nervous system inflammatory demyelinating diseases like neuromyelitis optica spectrum disorders (nmosd). |
2021-04-05 |
2023-08-13 |
Not clear |
| Madina Tugizova, Haojun Feng, Anna Tomczak, Kristen Steenerson, May Ha. Case series: Hearing loss in neuromyelitis optica spectrum disorders. Multiple sclerosis and related disorders. vol 41. 2021-03-29. PMID:32155460. |
aquaporin 4 (aqp4)- and myelin oligodendrocyte glycoprotein (mog)-associated neuromyelitis optica spectrum disorders (nmosd) are thought to primarily affect the central nervous system (cns). |
2021-03-29 |
2023-08-13 |
Not clear |
| Joyutpal Das, Atta Gill, Christine Lo, Natalie Chan-Lam, Siân Price, Stephen B Wharton, Helen Jessop, Basil Sharrack, John A Snowde. A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature. Frontiers in immunology. vol 11. 2021-03-29. PMID:32431694. |
neuromyelitis optica (nmo) and myelin oligodendrocyte glycoprotein (mog) antibodies were negative. |
2021-03-29 |
2023-08-13 |
Not clear |
| Satoru Tanaka, Baku Hashimoto, Shoko Izaki, Satoru Oji, Hikoaki Fukaura, Kyoichi Nomur. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts. Multiple sclerosis and related disorders. vol 41. 2021-03-22. PMID:32114369. |
patients with anti-aquaporin-4 (aqp4) water channel antibody-positive neuromyelitis optica spectrum disorders (aqp4-nmosd) and myelin oligodendrocyte glycoprotein (mog) associated disease (mogad) often present with similar clinical symptoms, and some cases are hard to differentiate at the time of onset. |
2021-03-22 |
2023-08-13 |
Not clear |
| Elisabeth Maillart, Françoise Durand-Dubief, Céline Louapre, Bertrand Audoin, Bertrand Bourre, Nathalie Derache, Jonathan Ciron, Nicolas Collongues, Jérome de Sèze, Mikael Cohen, Christine Lebrun-Frenay, Nawel Hadhoum, Hélène Zéphir, Romain Deschamps, Clarisse Carra-Dallière, Pierre Labauge, Philippe Kerschen, Alexis Montcuquet, Sandrine Wiertlewski, David Laplaud, Gwenaëlle Runavot, Sandra Vukusic, Caroline Papeix, Romain Marignie. Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies. Journal of neuroinflammation. vol 17. issue 1. 2021-03-18. PMID:32326965. |
longitudinally extensive transverse myelitis (letm) is classically related to aquaporin (aqp4)-antibodies (ab) neuromyelitis optica spectrum disorders (nmosd) or more recently to myelin oligodendrocyte glycoprotein (mog)-ab associated disease. |
2021-03-18 |
2023-08-13 |
Not clear |
| Matthias Baumann, Frederik Bartels, Carsten Finke, Catherine Adamsbaum, Yael Hacohen, Kevin Rostás. E.U. paediatric MOG consortium consensus: Part 2 - Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 29. 2021-03-15. PMID:33158737. |
imaging plays a crucial role in differentiating the spectrum of paediatric acquired demyelinating syndromes (ads), which apart from myelin oligodendrocyte glycoprotein antibody associated disorders (mogad) includes paediatric multiple sclerosis (ms), aquaporin-4 antibody neuromyelitis optica spectrum disorders (nmosd) and unclassified patients with both monophasic and relapsing ads. |
2021-03-15 |
2023-08-13 |
Not clear |
| Marina Boziki, Styliani-Aggeliki Sintila, Panagiotis Ioannidis, Nikolaos Grigoriadi. Biomarkers in Rare Demyelinating Disease of the Central Nervous System. International journal of molecular sciences. vol 21. issue 21. 2021-03-02. PMID:33182495. |
multiple sclerosis (ms) needs to be differentially diagnosed from rare ms variants, acute disseminated encephalomyelitis (adem), the range of neuromyelitis optica spectrum disorders (nmosds), myelin oligodendrocyte glycoprotein (mog) antibody disease and other systemic inflammatory diseases. |
2021-03-02 |
2023-08-13 |
Not clear |
| Joshua P Harve. Comment on: Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment. Eye (London, England). 2021-02-20. PMID:33608641. |
comment on: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment. |
2021-02-20 |
2023-08-13 |
Not clear |
| Kazuo Fujihara, Lawrence J Coo. Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics. Current opinion in neurology. vol 33. issue 3. 2021-01-28. PMID:32374571. |
neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics. |
2021-01-28 |
2023-08-13 |
Not clear |
| Kazuo Fujihara, Lawrence J Coo. Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics. Current opinion in neurology. vol 33. issue 3. 2021-01-28. PMID:32374571. |
we reviewed present topics on neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein (mog)-antibody-associated disease (mogad). |
2021-01-28 |
2023-08-13 |
Not clear |
| Susanna Asseyer, Graham Cooper, Friedemann Pau. Pain in NMOSD and MOGAD: A Systematic Literature Review of Pathophysiology, Symptoms, and Current Treatment Strategies. Frontiers in neurology. vol 11. 2021-01-22. PMID:33473247. |
neuromyelitis optica spectrum disorders (nmosds) and myelin oligodendrocyte glycoprotein-antibody-associated disease (mogad) are autoimmune inflammatory disorders of the central nervous system (cns). |
2021-01-22 |
2023-08-13 |
Not clear |
| Hirokazu Uchigami, Noritoshi Arai, Mariko Sekiguchi, Atsubumi Ogawa, Tsutomu Yasuda, Akiko Seto, Toshiyuki Takahashi, Sousuke Takeuch. Anti-myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis mimicking limbic encephalitis: A case report. Multiple sclerosis and related disorders. vol 38. 2021-01-18. PMID:31733424. |
anti-myelin oligodendrocyte glycoprotein antibodies (mog-ab) have been detected in various disorders of the central nervous system including acute disseminated encephalomyelitis (adem), neuromyelitis optica spectrum disorders (nmosd), optic neuritis, myelitis, and cortical encephalitis. |
2021-01-18 |
2023-08-13 |
Not clear |
| A Cerveró, M J Sedano-Tous, J Madera, A López-de-Eguileta, A Casad. Use of ganglion cell layer analysis for diagnosing anti-glycoprotein neuromyelitis optica of oligodendrocyte myelin. Archivos de la Sociedad Espanola de Oftalmologia. vol 95. issue 3. 2020-12-31. PMID:31980323. |
use of ganglion cell layer analysis for diagnosing anti-glycoprotein neuromyelitis optica of oligodendrocyte myelin. |
2020-12-31 |
2023-08-13 |
Not clear |